HomeCTX • WSE
Captor Therapeutics SA
zł 51.20
Jan 29, 5:55:45 PM GMT+1 · PLN · WSE · Disclaimer
StockPL listed security
Previous close
zł 51.80
Day range
zł 51.20 - zł 52.00
Year range
zł 40.80 - zł 97.80
Market cap
238.74M PLN
Avg Volume
3.51K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
(PLN)Sep 2024Y/Y change
Revenue
3.53M25.44%
Operating expense
12.74M-26.44%
Net income
-10.24M35.07%
Net profit margin
-290.1448.24%
Earnings per share
——
EBITDA
-2.14M84.65%
Effective tax rate
——
Total assets
Total liabilities
(PLN)Sep 2024Y/Y change
Cash and short-term investments
48.82M-10.81%
Total assets
64.63M-10.91%
Total liabilities
23.52M-25.84%
Total equity
41.11M—
Shares outstanding
4.66M—
Price to book
5.87—
Return on assets
-36.33%—
Return on capital
-49.86%—
Net change in cash
(PLN)Sep 2024Y/Y change
Net income
-10.24M35.07%
Cash from operations
-6.16M-82.72%
Cash from investing
140.00K-79.53%
Cash from financing
-1.68M-338.01%
Net change in cash
-7.70M-288.06%
Free cash flow
3.38M203.28%
About
Founded
2015
Employees
105
Search
Clear search
Close search
Google apps
Main menu